{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:55:22Z","timestamp":1788479722385,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11102-020-01039-x","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T07:02:35Z","timestamp":1586415755000},"page":"307-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Do nothing but observe microprolactinomas: when and how to replace sex hormones?"],"prefix":"10.1007","volume":"23","author":[{"given":"Vivien","family":"Bonert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"1039_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Coloa A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485","journal-title":"Endocr Rev"},{"key":"1039_CR2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631","journal-title":"Physiol Rev"},{"key":"1039_CR3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-68-2-412","volume":"68","author":"J Schlechte","year":"1989","unstructured":"Schlechte J, Dolan K, Sherman B, Chap-ler F, Luciano A (1989) The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68:412\u2013418","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2265.1996.00824.x","volume":"45","author":"WJ Jeffcoate","year":"1996","unstructured":"Jeffcoate WJ, Pound N, Sturrock ND, Lambourne J (1996) Long-term follow-up of patients with hyperprolactinaemia. Clin Endo 45:299\u2013303","journal-title":"Clin Endo"},{"key":"1039_CR5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9378(77)90594-4","volume":"129","author":"LA Rigg","year":"1977","unstructured":"Rigg LA, Lein A, Yen SS (1977) Patterns of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol 129:454\u2013456","journal-title":"Am J Obstet Gynecol"},{"key":"1039_CR6","first-page":"64","volume":"39","author":"H Din\u010d","year":"1998","unstructured":"Din\u010d H, Esen F, Demirci A, Sari A, Resit GH (1998) Pituitary dimensions and volume measurements during pregnancy and postpartum. MRI Assess Acta Radiol 39:64\u201369","journal-title":"MRI Assess Acta Radiol"},{"key":"1039_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.181.2.1924800","volume":"181","author":"AD Elster","year":"1991","unstructured":"Elster AD, Sanders TG, Vines FS, Chen MY (1991) Size and shape of the pituitary gland during pregnancy and post partum Measurement with MR imaging. Radiology 181:531","journal-title":"Radiology"},{"key":"1039_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(88)80346-2","volume":"85","author":"JG Gonzales","year":"1988","unstructured":"Gonzales JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ (1988) Pituitary gland growth during normal pregnancy. An in vivo study using magnetic resonance imaging. Am J Med 85:217\u2013220","journal-title":"Am J Med"},{"key":"1039_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","volume":"48","author":"W Huang","year":"2019","unstructured":"Huang W, Molitch ME (2019) Pituitary tumors in pregnancy. Endocrinol Metab Clin North Am 48:569\u2013581","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1039_CR10","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","volume":"172","author":"ME Molitch","year":"2015","unstructured":"Molitch ME (2015) Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. Eur J Endocrinol 172:R205\u2013R213","journal-title":"Eur J Endocrinol"},{"key":"1039_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513599709152546","volume":"11","author":"LA Balint-Peri\u0107","year":"1997","unstructured":"Balint-Peri\u0107 LA, Prelevi\u0107 GM (1997) Changes in prolactin levels with the menopause: the effects of estrogen\/androgen and calcitonin treatment. Gynecol Endocrinol 11:275\u2013280","journal-title":"Gynecol Endocrinol"},{"key":"1039_CR12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9378(77)90097-7","volume":"129","author":"FI Reyes","year":"1977","unstructured":"Reyes FI, Winter JS, Faiman CI (1977) Pituitary-ovarian relationships preceding the menopause. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129:557\u2013564","journal-title":"Am J Obstet Gynecol"},{"key":"1039_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2265.2001.01190.x","volume":"54","author":"S Karunakaran","year":"2001","unstructured":"Karunakaran S, Page RC, Wass JA (2001) The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol 54:295\u2013300","journal-title":"Clin Endocrinol"},{"key":"1039_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","volume":"95","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Lagro J, Burman P, Jorgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta- analysis. J Clin Endocrinol Metab 95:43\u201351","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","volume":"18","author":"J Hu","year":"2015","unstructured":"Hu J, Zheng X, Zhang W, Yang H (2015) Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta- analysis. Pituitary 18:745\u2013751","journal-title":"Pituitary"},{"key":"1039_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/2359-3997000000138","volume":"60","author":"MS Mallea-Gil","year":"2016","unstructured":"Mallea-Gil MS, Manavela M, Alfieri A, Ballarino MC, Chervin A, Danilowicz K, Diez S et al (2016) Prolactinomas: evolution after menopause. Arch Endocrinol Metab 60:42\u201346","journal-title":"Arch Endocrinol Metab"},{"key":"1039_CR17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/cen.13765","volume":"89","author":"S Santharam","year":"2018","unstructured":"Santharam S, Athanasios F, Arlt MW, Ayuk J, Gittoes N, Toogood A, Karavitaki N (2018) Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal. Clin Endocrinol 89:346\u2013353","journal-title":"Clin Endocrinol"},{"key":"1039_CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12672-019-00363-4","volume":"10","author":"R Indirli","year":"2019","unstructured":"Indirli R, Ferrante E, Sala E, Giavoli C, Mantovani G, Arosio M (2019) Cabergoline withdrawal before and after menopause: outcomes in microprolactinomas. Horm Cancer 10:120\u2013127","journal-title":"Horm Cancer"},{"key":"1039_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mce.2013.09.016","volume":"382","author":"Y Devi","year":"2014","unstructured":"Devi Y, Halperin J (2014) Reproductive actions of prolactin mediated through short and long receptor isoforms. Mol Cell Endocrinol 382:400\u2013410","journal-title":"Mol Cell Endocrinol"},{"key":"1039_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.286.6361.257","volume":"286","author":"AS Mcneilly","year":"1983","unstructured":"Mcneilly AS, Robinson JC, Houston MJ et al (1983) Release of oxytocin and prolactin in response to suckling. Br Med J 286:257\u2013259","journal-title":"Br Med J"},{"key":"1039_CR21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jne.12223","volume":"26","author":"RS Brown","year":"2014","unstructured":"Brown RS, Herbison AE, Grattan DR (2014) Prolactin regulation of kisspeptin neurons in the mouse brain and its role in the lactation-induced suppression of kisspeptin expression. J Neuroendocrinol 26:898\u2013908","journal-title":"J Neuroendocrinol"},{"key":"1039_CR22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","volume":"54","author":"R Demura","year":"1982","unstructured":"Demura R, Ono M, Demura H, Shizume K, Oouchi H (1982) Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17b-estradiol in the human ovary. J Clin Endocrinol Metab 54:1246\u20131250","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/mend-4-1-13","volume":"4","author":"JS Krasnow","year":"1990","unstructured":"Krasnow JS, Hickey GJ, Richard JS (1990) Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol Endocrinol 4:13\u201322","journal-title":"Mol Endocrinol"},{"key":"1039_CR24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/endo-110-5-1701","volume":"110","author":"JH Dorrington","year":"1982","unstructured":"Dorrington JH, Gore-Langton RE (1982) Antigonadal action of prolactin: further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures. Endocrinology 110:1701\u20131707","journal-title":"Endocrinology"},{"key":"1039_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2011.05.004","volume":"356","author":"J Bouilly","year":"2012","unstructured":"Bouilly J, Sonigo C, Auffret J et al (2012) Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol 356:80\u201387","journal-title":"Mol Cell Endocrinol"},{"key":"1039_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","volume":"31","author":"M Seppala","year":"1976","unstructured":"Seppala M, Ranta T, Hirvonen E (1976) Hyperprolactinaemia and luteal insufficiency. Lancet 31:229\u2013230","journal-title":"Lancet"},{"key":"1039_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","volume":"14","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14:299\u2013306","journal-title":"Pituitary"},{"key":"1039_CR28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1210\/jcem-64-5-1021","volume":"64","author":"J Schlechte","year":"1987","unstructured":"Schlechte J, el-Khoury G, Kathol M et al (1987) Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 64:1021\u20131026","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jcem-67-1-124","volume":"67","author":"A Klibanski","year":"1988","unstructured":"Klibanski A, Biller BMK, Rosenthal DI, Schoenfeld DA, Saxe V (1988) Eects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 67:124\u2013130","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jcb.22161","volume":"107","author":"D Seriwatanachai","year":"2009","unstructured":"Seriwatanachai D, Krishnamra N, van Leeuwen JPTM (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107:677\u2013685","journal-title":"J Cell Biochem"},{"key":"1039_CR31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK et al (2001) Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group. Lancet 357:425\u2013431","journal-title":"Lancet"},{"key":"1039_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2015.12.005","volume":"67","author":"RA Kloner","year":"2016","unstructured":"Kloner RA, Carson C 3rd, Dobs A, Kopecky S, Mohler ER 3rd (2016) Testosterone and cardiovascular disease. J Am Coll Cardiol 67:545\u2013557","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1039_CR33","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2011-1419","volume":"96","author":"N Santoro","year":"2011","unstructured":"Santoro N (2011) Update in hyper- and hypogonadotropic amenorrhea. J Clin Endocrinol Metab 96(11):3281\u20133288","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2265.2005.02364.x","volume":"63","author":"K Berinder","year":"2005","unstructured":"Berinder K, Stackenas I, Akre O, Hirschberg AL, Hulting AL (2005) Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol 63:450\u2013455","journal-title":"Clin Endocrinol"},{"key":"1039_CR35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline comparative study group. N Engl J Med 331:904\u2013909","journal-title":"N Engl J Med"},{"issue":"43\u201351","key":"1039_CR36","first-page":"89","volume":"95","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Lagro J, Burman P, J\u00f8rgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta- analysis. J Clin Endocrinol Metab 95(43\u201351):89","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR37","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","volume":"94","author":"J Kharlip","year":"2009","unstructured":"Kharlip J, Salvatori R, Yenokyan G, Wand GS (2009) Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 94:2428\u20132436","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR39","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, Zarrilli S, Lombardi G (2004) Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 89:1704\u20131711","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","volume":"37","author":"T Mancini","year":"2008","unstructured":"Mancini T, Casanueva FF, Giustina A (2008) Hyperprolactinemia and Prolactinomas. Endocrinol Metab Clin N Am 37:67\u201399","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1039_CR41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinoma. Clin Endocrinol 65:265\u2013273","journal-title":"Clin Endocrinol"},{"key":"1039_CR42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(16)55819-1","volume":"59","author":"B Corenblum","year":"1993","unstructured":"Corenblum B, Donovan L (1993) The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 59:671\u2013673","journal-title":"Fertil Steril"},{"key":"1039_CR43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","volume":"73","author":"M Lebbe","year":"2010","unstructured":"Lebbe M, Hubinont C, Bernard P, Maiter D (2010) Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinemic women. Clin Endocrinol 73:236\u2013242","journal-title":"Clin Endocrinol"},{"key":"1039_CR44","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","volume":"95","author":"M Ono","year":"2010","unstructured":"Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K et al (2010) High-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroproalctinomas. J Clin Endocrinol Metab 95:2672\u20132679","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","volume":"77","author":"D Maiter","year":"2016","unstructured":"Maiter D (2016) Prolactinoma and Pregnancy: From wish to conception. Ann d\u2019 Endocrinol 77:128\u2013134","journal-title":"Ann d\u2019 Endocrinol"},{"key":"1039_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002229.pub4","author":"HM Boardman","year":"2015","unstructured":"Boardman HM, Hartley L, Eisinga A, Main C, iFiguls MR, Cosp X, Gabriel Sanchez R, Knight B (2015) Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002229.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1039_CR47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2008-1878","volume":"94","author":"VB Popat","year":"2009","unstructured":"Popat VB, Calis KA, Vanderhoof VH, Cizza G, Reynolds JC, Sebring N, Troendle JF, Nelson LM (2009) Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 94:2277\u20132283","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR48","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1210\/jc.2005-1207","volume":"90","author":"PM Mah","year":"2005","unstructured":"Mah PM, Webster J, J\u00f6nsson P, Feldt-Rasmussen U, Koltowska-H\u00e4ggstr\u00f6m M, Ross RJ (2005) Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab 90:5964\u20135969","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4615-1435-0_9","volume-title":"Pituitary tumors in pregnancy","author":"P Serafini","year":"2001","unstructured":"Serafini P, Motta EL, White JS (2001) Restoration of ovarian cyclicity and ovulation induction in hypopituitary women. In: Bronstein MD (ed) Pituitary tumors in pregnancy. Kluwer Academic Publishers, Boston, pp 173\u2013194"},{"key":"1039_CR50","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ et al (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103:1715\u20131744","journal-title":"J Clin Endocrinol Metab"},{"key":"1039_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/EJE-09-0084","volume":"161","author":"RS Ribeiro","year":"2009","unstructured":"Ribeiro RS, Abucham J (2009) Recovery of persistent hypogonadism by clomiphene in male with prolactinomas under dopamine agonist treatment. Eur J Endocrinol 161:163\u2013169","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-020-01039-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T18:20:08Z","timestamp":1722709208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-020-01039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01039-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"9 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human subjects or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}}]}}